These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 35894223)
1. Pediatric autoimmune blistering disorders - a five-year demographic profile and therapy experience. Mahajan R; Handa S; Kumar S; Chatterji D; Saikia UN; De D Int J Dermatol; 2022 Dec; 61(12):1511-1518. PubMed ID: 35894223 [TBL] [Abstract][Full Text] [Related]
2. Retrospective analysis of autoimmune bullous diseases in Middle Franconia. Sollfrank L; Schönfelder V; Sticherling M Front Immunol; 2023; 14():1256617. PubMed ID: 37881435 [TBL] [Abstract][Full Text] [Related]
3. Retrospective Study on Autoimmune Blistering Disease in Paediatric Patients. Kong YL; Lim YL; Chandran NS Pediatr Dermatol; 2015; 32(6):845-52. PubMed ID: 26391853 [TBL] [Abstract][Full Text] [Related]
4. Spectrum of Autoimmune Bullous Diseases in Northern Greece. A 4-year Retrospective Study and Review of the Literature. Patsatsi A; Lamprou F; Kokolios M; Stylianidou D; Trigoni A; Kalampalikis D; Sotiriadis D Acta Dermatovenerol Croat; 2017 Oct; 25(3):195-201. PubMed ID: 29252171 [TBL] [Abstract][Full Text] [Related]
6. Spectrum of autoimmune bullous diseases among children in Kuwait. Nanda A; Lazarevic V; Rajy JM; Almasry IM; AlSabah H; AlLafi A Pediatr Dermatol; 2021 Jan; 38(1):50-57. PubMed ID: 33043506 [TBL] [Abstract][Full Text] [Related]
7. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari. Atzori L; Deidda S; Aste N G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046 [TBL] [Abstract][Full Text] [Related]
8. Rituximab in childhood and juvenile autoimmune bullous diseases as first-line and second-line treatment: a case series of 13 patients. Kianfar N; Dasdar S; Mahmoudi H; Tavakolpour S; Balighi K; Daneshpazhooh M J Dermatolog Treat; 2022 Mar; 33(2):869-874. PubMed ID: 32589481 [TBL] [Abstract][Full Text] [Related]
12. Rituximab therapy in pediatric pemphigus patients: A retrospective analysis of five Turkish patients and review of the literature. Bilgic-Temel A; Özgen Z; Harman M; Kapıcıoğlu Y; Uzun S Pediatr Dermatol; 2019 Sep; 36(5):646-650. PubMed ID: 31355479 [TBL] [Abstract][Full Text] [Related]
13. Pruritus Is Associated with an Increased Risk for the Diagnosis of Autoimmune Skin Blistering Diseases: A Propensity-Matched Global Study. Raap U; Limberg MM; Kridin K; Ludwig RJ Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979421 [TBL] [Abstract][Full Text] [Related]
14. Rituximab in Subepidermal Blistering Diseases. Tan WH; Sim J; Sultana R; Lee HY Dermatology; 2023; 239(1):5-11. PubMed ID: 36302346 [TBL] [Abstract][Full Text] [Related]
15. A survey of bullous diseases in a Turkish university hospital: clinicoepidemiological characteristics and follow-up. Kutlubay Z; Sevim Keçici A; Çelik U; Mat MC Turk J Med Sci; 2021 Feb; 51(1):124-133. PubMed ID: 32892539 [TBL] [Abstract][Full Text] [Related]
16. Immunobullous diseases in Thai children: report of 24 cases. Singalavanija S; Limpongsanurak W J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S681-8. PubMed ID: 14700167 [TBL] [Abstract][Full Text] [Related]
17. Clinical, demographic and immunopathological spectrum of subepidermal autoimmune bullous diseases at a tertiary center: A 1-year audit. De D; Khullar G; Handa S; Saikia UN; Radotra BD; Saikia B; Minz RW Indian J Dermatol Venereol Leprol; 2016; 82(3):358. PubMed ID: 27088957 [TBL] [Abstract][Full Text] [Related]